+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Oncogene"

BET inhibitor - Pipeline Insight, 2022 - Product Thumbnail Image

BET inhibitor - Pipeline Insight, 2022

  • Drug Pipelines
  • January 2022
  • 60 Pages
From
BRAFV600 mutation (B-Raf proto-oncogene, serine/threonine kinase) Inhibiotors - Pipeline Insight, 2022 - Product Thumbnail Image

BRAFV600 mutation (B-Raf proto-oncogene, serine/threonine kinase) Inhibiotors - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 90 Pages
From
FTase (Farnesyltransferase) inhibitor- Pipeline Insight, 2022 - Product Thumbnail Image

FTase (Farnesyltransferase) inhibitor- Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 60 Pages
From
Gene Therapy - Technologies, Markets & Companies - Product Thumbnail Image

Gene Therapy - Technologies, Markets & Companies

  • Report
  • November 2021
  • 802 Pages
From
Exosome Diagnostics and Therapeutics: Global Markets 2021-2026 - Product Thumbnail Image

Exosome Diagnostics and Therapeutics: Global Markets 2021-2026

  • Report
  • November 2021
  • 255 Pages
From
RNAi - Technologies, Markets & Companies - Product Thumbnail Image

RNAi - Technologies, Markets & Companies

  • Report
  • November 2021
  • 527 Pages
From
Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market & Clinical Trials Insight 2026 - Product Thumbnail Image

Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market & Clinical Trials Insight 2026

  • Report
  • November 2021
  • 222 Pages
From
Drug Delivery in Cancer - Technologies, Markets & Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets & Companies

  • Report
  • November 2021
  • 747 Pages
From
Personalized Medicine - Scientific & Commercial Aspects - Product Thumbnail Image

Personalized Medicine - Scientific & Commercial Aspects

  • Report
  • November 2021
  • 1165 Pages
From
Lumakras Drug Clinical Insight & Sales Forecast 2026 - Product Thumbnail Image

Lumakras Drug Clinical Insight & Sales Forecast 2026

  • Report
  • July 2021
  • 60 Pages
From
Tyrosine Protein Kinase Lyn (Lck/Yes Related Novel Protein Tyrosine Kinase or V Yes 1 Yamaguchi Sarcoma Viral Related Oncogene Homolog or p53Lyn or p56Lyn or LYN or EC 2.7.10.2) - Drugs in Development, 2021 - Product Thumbnail Image

Tyrosine Protein Kinase Lyn (Lck/Yes Related Novel Protein Tyrosine Kinase or V Yes 1 Yamaguchi Sarcoma Viral Related Oncogene Homolog or p53Lyn or p56Lyn or LYN or EC 2.7.10.2) - Drugs in Development, 2021

  • Report
  • April 2021
  • 40 Pages
From
Proto Oncogene Mas (MAS1) - Drugs in Development, 2021 - Product Thumbnail Image

Proto Oncogene Mas (MAS1) - Drugs in Development, 2021

  • Report
  • April 2021
  • 35 Pages
From
2021 Global Tumor Marker Testing Market - Competitive Shares and Strategic SWOT Analysis, Volume and Sales Segmentation Forecasts for Major Cancer Diagnostic Tests - Product Thumbnail Image

2021 Global Tumor Marker Testing Market - Competitive Shares and Strategic SWOT Analysis, Volume and Sales Segmentation Forecasts for Major Cancer Diagnostic Tests

  • Report
  • April 2021
  • 1200 Pages
From
Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Drugs in Development, 2021 - Product Thumbnail Image

Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
From
Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) - Drugs in Development, 2021 - Product Thumbnail Image

Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
From
Relapsed or Refractory Myelodysplastic Syndrome - Pipeline Insight, 2021 - Product Thumbnail Image

Relapsed or Refractory Myelodysplastic Syndrome - Pipeline Insight, 2021

  • Clinical Trials
  • February 2021
  • 60 Pages
From
Myc Proto Oncogene Protein - Pipeline Review, H2 2020 - Product Thumbnail Image

Myc Proto Oncogene Protein - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 56 Pages
From
2020-2025 Qatar Cancer Diagnostics Market Segmentation Analysis and Database: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Emerging Technologies, Latest Instrumentation, Growth Opportunities - Product Thumbnail Image

2020-2025 Qatar Cancer Diagnostics Market Segmentation Analysis and Database: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Emerging Technologies, Latest Instrumentation, Growth Opportunities

  • Report
  • October 2020
  • 535 Pages
From
2020-2025 Taiwan Cancer Diagnostics Market Segmentation Analysis and Database: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Emerging Technologies, Latest Instrumentation, Growth Opportunities - Product Thumbnail Image

2020-2025 Taiwan Cancer Diagnostics Market Segmentation Analysis and Database: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Emerging Technologies, Latest Instrumentation, Growth Opportunities

  • Report
  • October 2020
  • 535 Pages
From
2020-2025 Singapore Cancer Diagnostics Market Segmentation Analysis and Database: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Emerging Technologies, Latest Instrumentation, Growth Opportunities - Product Thumbnail Image

2020-2025 Singapore Cancer Diagnostics Market Segmentation Analysis and Database: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Emerging Technologies, Latest Instrumentation, Growth Opportunities

  • Report
  • October 2020
  • 535 Pages
From
Loading Indicator